News

Healthcare 2011 and beyond: Part 2

Medicaid is a state-run program that helps pay medical costs for some people with limited income and resources and meet other eligibility requirements. Medicaid also offers benefits not normally covered by Medicare, like help with personal care and rides to doctor appointments. If you qualify for Medicaid in your state, you automatically qualify to get Extra Help paying for Medicare prescription drug coverage.

By |2019-12-26T12:54:00-05:00April 1st, 2011|Advocacy, News|

Dating with GIST: the who, what, when and just plain how? (Part 2)

The perilous world of dating can become even more complicated when you are living with cancer. This article is the second in a two part series on dating with a diagnosis of GIST. Part one, which was published in the February 2011 issue of the LRG newsletter featured experiences from three GIST survivors, Jason DeLorenzo, Eric Tan & Estelle Lecointe on the difficulties approaching the subject of GIST while dating. Part two covers tips on approaching the subject, a success story and new ways to meet people.

By |2019-12-26T12:46:29-05:00April 1st, 2011|News, Pediatric GIST|

Breaking News Update: TDM renews plasma testing

On April 21, 2010, the U.S. Food and Drug Administration (FDA) issued a warning letter to Novartis criticizing its promotion of blood level testing on its CML and GIST Alliance websites. As of September 30, 2010, Novartis terminated the CML and GIST Alliance programs which it had contracted with TDM Pharmaceutical Research, LLC. Since then, the Life Raft Group has been working tirelessly behind the scenes to try and resume this critical testing procedure as it has important potential for managing GIST patient care.

By |2019-04-08T09:08:13-04:00April 1st, 2011|News|

State of the GIST community: Life Raft Group’s patient registry demographics

As of December 31, 2010 the Life Raft Group’s Patient Registry has now accounted for 1,279 cases of GIST. The members of this registry have reported their clinical information to us as it pertains to their treatment of GIST. Of these 1,279 cases, we are here to report some key demographics that will help you understand who is a part of Life Raft Group GIST Community.

By |2019-12-26T14:31:38-05:00February 1st, 2011|News, Patient Registry|

National Organization for Rare Disorders Hosts Forum for FDA Commissioner and Patient Leaders

Food and Drug Commissioner Dr. Margaret Hamburg today conducted an unusual one-on-one dialogue with leaders of approximately 60 patient organizations at a forum hosted by the National Organization for Rare Disorders (NORD).

By |2019-12-26T14:30:48-05:00February 1st, 2011|News|

Latin American GIST Coalition, new challenges on the horizon for 2010

The year 2010 is gone, an important year for the Latin American GIST Coalition. In 2010 the Monterrey Declaration was signed during the first summit meeting of the group. The group had the privilege of meeting the LRG research team, who works on a daily basis to find the cure for GIST.

By |2019-12-26T14:29:52-05:00February 1st, 2011|News|
Go to Top